CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.63%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.21B
AUM Growth
+$7.21B
(+11%)
Cap. Flow
+$312M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
73.33%
Holding
137
New
11
Increased
45
Reduced
45
Closed
6
Top Buys
| 1 |
Coca-Cola
KO
|
$300M |
| 2 |
Procter & Gamble
PG
|
$113M |
| 3 |
HDFC Bank
HDB
|
$15.9M |
| 4 |
Merck
MRK
|
$7.84M |
| 5 |
Alkermes
ALKS
|
$6.65M |
Top Sells
| 1 |
TSMC
TSM
|
$71.3M |
| 2 |
Visa
V
|
$18.7M |
| 3 |
Home Depot
HD
|
$9.69M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$9.36M |
| 5 |
Glaukos
GKOS
|
$8.09M |
Sector Composition
| 1 | Financials | 29.05% |
| 2 | Consumer Discretionary | 18.26% |
| 3 | Communication Services | 15.15% |
| 4 | Healthcare | 13.9% |
| 5 | Consumer Staples | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Puma Biotechnology
PBYI
$254M
| $3.82M | 0.05% | 64,585 +40,703 | +170% | +$2.41M |
|
|
TSRO
77
DELISTED
TESARO, Inc.
TSRO
| $3.82M | 0.05% | 85,872 +83,480 | +3,490% | +$3.71M |
|
78
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.74M | 0.05% | 267,157 +93,942 | +54% | +$1.32M |
|
79
Collegium Pharmaceutical
COLL
$1.22B
| $3.54M | 0.05% | +148,244 | New | +$3.54M |
|
80
Acadia Healthcare
ACHC
$2.12B
| $3.54M | 0.05% | 86,405 +36,405 | +73% | +$1.49M |
|
81
Hologic
HOLX
$14.9B
| $3.53M | 0.05% | 88,877 | – | – |
|
|
STML
82
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.43M | 0.05% | 213,706 +43,711 | +26% | +$702K |
|
83
NeoGenomics
NEO
$1.13B
| $3.14M | 0.04% | 239,681 +48,073 | +25% | +$630K |
|
|
84
Glaukos
GKOS
$5.5B
| $3.14M | 0.04% | 77,201 -199,071 | -72% | -$8.09M |
|
85
Incyte
INCY
$16.5B
| $3.07M | 0.04% | 45,826 +8,951 | +24% | +$600K |
|
|
ITCI
86
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.07M | 0.04% | 173,656 +36,253 | +26% | +$641K |
|
|
EGRX
87
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.88M | 0.04% | 38,070 +7,141 | +23% | +$540K |
|
88
Zevra Therapeutics
ZVRA
$509M
| $2.6M | 0.04% | 399,999 +12,319 | +3% | +$80.1K |
|
89
Insulet
PODD
$23.9B
| $2.53M | 0.04% | 29,495 +5,747 | +24% | +$493K |
|
90
Open Text
OTEX
$8.41B
| $2.24M | 0.03% | 48,478 -20,822 | -30% | -$963K |
|
91
Crown Castle
CCI
$43.2B
| $2.15M | 0.03% | +19,900 | New | +$2.15M |
|
92
Algonquin Power & Utilities
AQN
$4.45B
| $2.13M | 0.03% | 167,900 | – | – |
|
|
OXFD
93
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.12M | 0.03% | 164,073 +33,059 | +25% | +$426K |
|
|
ELGX
94
DELISTED
Endologix Inc
ELGX
| $2.06M | 0.03% | 364,464 +66,486 | +22% | +$376K |
|
|
VCRA
95
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.06M | 0.03% | +68,804 | New | +$2.06M |
|
|
BKI
96
DELISTED
Black Knight, Inc. Common Stock
BKI
| $2.04M | 0.03% | +38,000 | New | +$2.04M |
|
|
PFNX
97
DELISTED
Pfenex Inc.
PFNX
| $1.96M | 0.03% | 363,068 +161,794 | +80% | +$875K |
|
98
Snap-on
SNA
$17B
| $1.78M | 0.02% | 11,063 -4,444 | -29% | -$714K |
|
99
Elevance Health
ELV
$71.8B
| $1.75M | 0.02% | 7,364 +2,364 | +47% | +$563K |
|
100
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.68M | 0.02% | 28,058 -9,908 | -26% | -$593K |
|